Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022847
Filing Date
2019-11-14
Accepted
2019-11-14 12:08:54
Documents
45
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20190930_10q.htm 10-Q 907520
2 EXHIBIT 31.1 ex_161212.htm EX-31.1 17019
3 EXHIBIT 31.2 ex_161213.htm EX-31.2 13658
4 EXHIBIT 32.1 ex_161214.htm EX-32.1 9900
  Complete submission text file 0001437749-19-022847.txt   3446728

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnpx-20190930.xml EX-101.INS 440746
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20190930.xsd EX-101.SCH 35149
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20190930_cal.xml EX-101.CAL 23208
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20190930_def.xml EX-101.DEF 267380
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20190930_lab.xml EX-101.LAB 243729
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20190930_pre.xml EX-101.PRE 284535
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 191218105
SIC: 2834 Pharmaceutical Preparations